Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial Results

Jacqueline A. Pongracic(Lurie Children's Hospital), Philippe Bégin(Université de Montréal), Terri F. Brown‐Whitehorn(Children's Hospital of Philadelphia), Sayantani Sindher(Johns Hopkins University), Amy M. Scurlock(Arkansas Children's Hospital), Allan Stillerman(Asthma and Allergy Specialists), Hugh A. Sampson(Icahn School of Medicine at Mount Sinai), Roxanne C. Oriel(Icahn School of Medicine at Mount Sinai), David M. Fleischer(Children's Hospital Colorado), Andrew J. MacGinnitie(Boston Children's Hospital), Dareen Siri(Mid Illinois Hematology and Oncology Associates), J. Andrew Bird, Amarjit Cheema(Research Canada), Hemalini Mehta(Asthma and Allergy Specialists), Dianne E. Campbell(The University of Sydney), Daniel Petroni(Allergy Asthma Research Institute), Timothée Bois(DBV Technologies (France)), Hey Chong(Children's Hospital of Pittsburgh), Bruce J. Lanser(Johns Hopkins University), Erika Gonzalez-Reyes(Allergy and Asthma Medical Group and Research Center), Stanley M. Fìneman(Emory University), Lynda C. Schneider(Boston Children's Hospital), Paul Dowling(Children's Mercy Hospital), Edwin Kim(University of North Carolina at Chapel Hill), Todd D. Green(DBV Technologies (France)), Wayne G. Shreffler(Massachusetts General Hospital), Sara Anvari(High Institute for Education and Research in Transfusion Medicine), Robert A. Wood(Johns Hopkins University), William E. Berger(California Allergy and Asthma Medical Group), Lawrence Sher(Peninsula Research), Gordon L. Sussman(Ontario Ministry of Labour), William H. Yang(Ottawa Allergy Research Corporation), Ned T. Rupp, Edmond S. Chan(University of British Columbia), Rémi Gagnon, R. Sharon Chinthrajah(Stanford University)
The Journal of Allergy and Clinical Immunology In Practice
November 27, 2021
Cited by 61


Related Papers